Pregnancy and obesity modify the epithelial composition and hormone signaling state of the human breast

parity affect the mammary epithelial microenvironment to modify breast cancer susceptibility.

[1]  Daniel J. Gaffney,et al.  souporcell: Robust clustering of single cell RNAseq by genotype and ambient RNA inference without reference genotypes , 2019, bioRxiv.

[2]  Jennifer L Hu,et al.  MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices , 2019, Nature Methods.

[3]  R. Satija,et al.  Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression , 2019, Genome Biology.

[4]  B. Rosner,et al.  Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses’ Health Studies , 2019, Breast Cancer Research.

[5]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[6]  Eliah R. Shamir,et al.  Myoepithelial cells are a dynamic barrier to epithelial dissemination , 2018, The Journal of cell biology.

[7]  W. Willett,et al.  Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women , 2018, JAMA oncology.

[8]  Z. Werb,et al.  Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity , 2018, Nature Communications.

[9]  P. Hannaford,et al.  Contemporary Hormonal Contraception and the Risk of Breast Cancer , 2017, The New England journal of medicine.

[10]  L. Arendt,et al.  Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity , 2017, Breast Cancer Research.

[11]  A. Van Keymeulen,et al.  Lineage-Restricted Mammary Stem Cells Sustain the Development, Homeostasis, and Regeneration of the Estrogen Receptor Positive Lineage , 2017, Cell reports.

[12]  Wenjun Guo,et al.  Lineage-Biased Stem Cells Maintain Estrogen-Receptor-Positive and -Negative Mouse Mammary Luminal Lineages. , 2017, Cell reports.

[13]  C. Ng,et al.  Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue , 2017, Oncotarget.

[14]  Philippe Andrey,et al.  MorphoLibJ: integrated library and plugins for mathematical morphology with ImageJ , 2016, Bioinform..

[15]  O. Petersen,et al.  Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture , 2015, Nature Communications.

[16]  May Yin Lee,et al.  Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.

[17]  Michael B. Stadler,et al.  PIK3CAH1047R induces multipotency and multi-lineage mammary tumours , 2015, Nature.

[18]  J. Rougemont,et al.  Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk , 2015, The EMBO journal.

[19]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[20]  D. Buist,et al.  Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age. , 2014, Cancer research.

[21]  Alan Mackay,et al.  Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models , 2014, The Journal of pathology.

[22]  S. Swan,et al.  Differences in ovarian hormones in relation to parity and time since last birth. , 2014, Fertility and sterility.

[23]  H. Brinkhaus,et al.  Early but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling , 2014, Breast Cancer Research.

[24]  Piotr J. Balwierz,et al.  Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium , 2013, Breast Cancer Research.

[25]  Wassim Raffoul,et al.  Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast , 2013, Science Translational Medicine.

[26]  Heather Eliassen,et al.  Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies , 2012, The Lancet. Oncology.

[27]  J. Russo,et al.  Defining the genomic signature of the parous breast , 2012, BMC Medical Genomics.

[28]  C. Perou,et al.  Defining the cellular precursors to human breast cancer , 2011, Proceedings of the National Academy of Sciences.

[29]  E. Lander,et al.  Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. , 2011, Cell stem cell.

[30]  A. Ashworth,et al.  BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. , 2010, Cell stem cell.

[31]  B. Vojtesek,et al.  The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers , 2010, Oncogene.

[32]  C. Brisken,et al.  Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland , 2010, Proceedings of the National Academy of Sciences.

[33]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[34]  A. Ashworth,et al.  Pregnancy and the risk of breast cancer. , 2007, Endocrine-related cancer.

[35]  V. Beral,et al.  Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study , 2007, BMJ : British Medical Journal.

[36]  J. Hanoune.  Amphiregulin is an essential mediator of estrogen receptor a function in mammary gland development. , 2007 .

[37]  Romayne A. Thompson,et al.  Age-related lobular involution and risk of breast cancer. , 2006, Journal of the National Cancer Institute.

[38]  M. Pike,et al.  Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies , 2006, Breast Cancer Research.

[39]  T. Kodadek.  Faculty Opinions recommendation of Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. , 2004 .

[40]  Mark Garton,et al.  Breast cancer and hormone-replacement therapy: the Million Women Study , 2003, The Lancet.

[41]  J R Marshall,et al.  Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. , 2000, American journal of epidemiology.

[42]  A. Nardulli,et al.  Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. , 2000, Molecular endocrinology.

[43]  F. Kittrell,et al.  Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. , 1999, Cancer research.

[44]  A. Howell,et al.  Dissociation between steroid receptor expression and cell proliferation in the human breast. , 1997, Cancer research.

[45]  Z. Shao,et al.  The human myoepithelial cell is a natural tumor suppressor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  H. Adami,et al.  Transient increase in the risk of breast cancer after giving birth. , 1994, The New England journal of medicine.

[47]  K. McPherson,et al.  Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. , 1992, British Journal of Cancer.

[48]  P Chambon,et al.  Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. , 1990, The EMBO journal.

[49]  Röbbe Wünschiers,et al.  Computational Biology , 2013, Springer Berlin Heidelberg.

[50]  K. Kliche,et al.  Premenopausal Breast Cancer , 2012, Drugs.

[51]  J. Russo,et al.  Influence of age and parity on the development of the human breast , 2005, Breast Cancer Research and Treatment.